Assays for resistance to echinocandin-class drugs

Details for Australian Patent Application No. 2006272568 (hide)

Owner University of Medicine and Dentistry of New Jersey Merck Sharp & Dohme Corp.

Inventors Perlin, David S.; Douglas, Cameron M.; Kelly, Rosemarie; Kahn, Jennifer Nielsen; Parent, Stephen A.; Park, Steven

Agent Spruson & Ferguson

Pub. Number AU-B-2006272568

PCT Pub. Number WO2007/014305

Priority 60/702,756 26.07.05 US

Filing date 26 July 2006

Wipo publication date 1 February 2007

Acceptance publication date 28 June 2012

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 19/00 Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/014305 Priority application(s): WO2007/014305

7 April 2011 Alteration of Name

  The name of the applicant has been altered to University of Medicine and Dentistry of New Jersey; Merck Sharp & Dohme Corp.

28 June 2012 Application Accepted

  Published as AU-B-2006272568

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272571-8-methoxy-9H-isothiazolo[5,4-B]quinoli ne-3,4-diones and related compounds as anti-infective agents

2006272567-Antibody profiles characteristic of tuberculosis state